Panaxia Labs Israel (XTAE:PNAX) 3-Year EBITDA Growth Rate : 45.60% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Panaxia Labs Israel 3-Year EBITDA Growth Rate?

Panaxia Labs Israel's EBITDA per Share for the three months ended in Dec. 2023 was ₪0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 45.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Panaxia Labs Israel was 45.60% per year. The lowest was -90.00% per year. And the median was -15.00% per year.

Competitive Comparison of Panaxia Labs Israel's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Panaxia Labs Israel's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panaxia Labs Israel's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panaxia Labs Israel's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Panaxia Labs Israel's 3-Year EBITDA Growth Rate falls into.

Panaxia Labs Israel 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Panaxia Labs Israel (XTAE:PNAX) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Panaxia Labs Israel 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Panaxia Labs Israel's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Panaxia Labs Israel (XTAE:PNAX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Panaxia Labs Israel Ltd (XTAE:PNAX) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jabotinsky Street 7, Ramat Gan, ISR, 52520

Website

https://www.panaxia.co.il

Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.

Panaxia Labs Israel (XTAE:PNAX) Headlines

No Headlines